Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Ideas On Trading Merck This Week

Published 01/20/2015, 09:01 AM
Updated 07/09/2023, 06:31 AM

Merck and Company, (MRK) has been moving in a sideways channel that on closer inspection shows a series of higher highs and now also a higher low. An uptrend? Since the start of 2015 it has moved higher quickly and then started a consolidation. A break of that consolidation to the upside carries a target of 68. The RSI on the daily chart is strongly in the bullish zone while the MACD is rising. Both support that break higher. Short interest is low at 1% and the company is expected to report earnings February 4th before the market opens.

MRK Daily
Merck Daily Chart

On the longer monthly chart this name gets very interesting. Sitting at 13 year resistance and coming off of a double bottom, the price action is tracing out a bearish Shark harmonic. This pattern has a Potential Reversal Zone PRZ I at 88.60 and PRZ II at 106.65 (not shown). The stock also carries a 2.90% dividend. There is resistance at 63 and then 68 followed by 72 and 76.50 before 80. Support lower comes at 61.75 and 60.30 followed by 58.75 and 56.75 before 53.40.

MRK Monthly
Merch Monthly Chart

Trade Idea 1: Buy the stock on a move over 63 with a stop at 61.50.
A straight buy for the move higher with protection.

Trade Idea 2: Buy the January 30 Expiry 63 Calls (offered at 86 cents late Friday).
A short term upside trade with risk defined to the premium paid.

Trade Idea 3: Buy the January 30 Expiry 61.5/63 bullish Risk Reversal (54 cents).
A short term upside trade with leverage from the short 61.5 Puts, relying the large Open Interest at the 62 Strike as a speed break should it fall.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Trade Idea 4: Buy the January 2016 Expiry 65 Calls ($3.85).
A longer term upside trade with defined risk.

Trade Idea 5: Buy the April/January 2016 Expiry 65 Call Calendar ($3.40).
A longer term upside trade, with lowered cost from the short April Calls. The plan would be to roll the short calls out, and up if necessary, as they near Expiration.

Trade Idea 6: Buy the stock and add a February 62.5/60 Put Spread, April 67.5 Covered Call, Collar (16 cents).
A longer term upside trade with protection through the earnings event with a low cost. Sell the Put Spread after earnings should the price fall, and if it rises above the Call Strike roll the Calls up and out, preferably for a credit.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.